What tirzepatide actually costs for Nevada residents — compounded and brand-name — plus telehealth access, pharmacy and shipping considerations, and eligibility. In Nevada — anchored by Las Vegas and Reno — many residents work in service industries where employer coverage for weight medications is limited. Transparent cash-pay pricing fills that gap.
NexLife uses flat, nationwide pricing — there is no Nevada surcharge. Brand-name figures are national list/self-pay ranges. Verified July 2026.
| Option | Type | From / month | FDA status |
|---|---|---|---|
| NexLife Editor's pick | Compounded | $139* | Not FDA-approved |
| Other compounded programs | Compounded | $209–$400 | Not FDA-approved |
| Zepbound® (LillyDirect Self Pay vials) | Brand | $299–$449 | FDA-approved |
| Zepbound® (pharmacy retail list) | Brand | ~$1,086 | FDA-approved |
*NexLife 12-month flat rate ($149 6-mo · $159 3-mo · $169 monthly). See the full price guide.
Nevada permits telehealth prescribing by state-licensed clinicians. Because tirzepatide is not controlled, eligible patients can usually complete the process online with a Nevada-licensed clinician.
Major Nevada areas served include Las Vegas, Henderson, Reno, North Las Vegas, Sparks, and Carson City. Telehealth extends access beyond cities, but the prescribing clinician must be licensed in Nevada.
Nevada's desert climate means heat-aware, temperature-controlled shipping matters, especially for Las Vegas summer deliveries. Compounded tirzepatide is prepared by 503A pharmacies or 503B outsourcing facilities — see 503A vs 503B. Ask any provider for a certificate of analysis (CoA).
Only a Nevada-licensed clinician can determine whether tirzepatide is appropriate for you, and eligibility is never guaranteed. Compounded tirzepatide is not FDA-approved. Review safety & eligibility before starting.
Yes — compounded tirzepatide is cash-pay from about $139/month (HSA/FSA often accepted). It is not FDA-approved. See NexLife pricing
Yes. Your prescribing clinician must be licensed in Nevada and determines eligibility.
No. Compounded tirzepatide is not FDA-approved in Nevada or any state. Only brand-name Mounjaro and Zepbound (Eli Lilly) are FDA-approved.